But the Philadelphia chromosome may be present in up to 10% of cases.

The Philadelphia chromosome is not passed from parent to child.

No blood or bone marrow cells containing the Philadelphia chromosome.

Philadelphia Chromosome is an example of this type of translocation event.

The changed chromosome 22 is called the Philadelphia chromosome.

The Philadelphia chromosome creates a new gene, called bcr-abl.

The Philadelphia chromosome no longer drives your disease alone, Radich says.

Bone marrow cells are looked at under a microscope to check for the abnormal Philadelphia chromosome.

The truncated copy was named the Philadelphia chromosome.

No cells with the Philadelphia chromosome can be found in your blood or bone marrow (complete cytogenic response).

The presence of the Philadelphia chromosome can help predict how the cancer will progress and provides a target for molecular therapies.

Whether the Philadelphia chromosome is present.

That material is designed to stop the Philadelphia chromosome from directing cells to make a protein that leads to cancer.

The combination produces a new chromosome, called the Philadelphia chromosome (named after the city where it was discovered).

This chromosomal abnormality, which is commonly called the Philadelphia chromosome, is found only in cancer cells.

It is a type of myeloproliferative disease associated with a characteristic chromosomal translocation called the Philadelphia chromosome.

There are four main myeloproliferative diseases, which can be further categorized by the presence of the Philadelphia chromosome:

Cytogeneticcally heterogeneous but frequently associated with Philadelphia chromosome.

Philadelphia chromosome.

Most people with CML have a gene mutation (change) called the Philadelphia chromosome.

(More information about the Philadelphia Chromosome below)

Chronic myelogenous leukemia (t9;22 - the Philadelphia chromosome)

Analysis of one of the first patients' white blood cells found no signs of the Philadelphia chromosome, suggesting the leukemia had been stopped at the source.

Patients with the Philadelphia chromosome have a potential for the development of acute leukemia, especially acute lymphocytic leukemia.

Identification of the Philadelphia chromosome by cytogenetics is diagnostic for CML.